Vistagen Therapeutics, Inc. SEC filings VTGN
Vistagen Therapeutics, Inc. has 908 filings in SEC EDGAR's recent list, going back to Sep 11, 2007. Its latest annual report, Form 10-K, was filed on Jun 15, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (exit or restructuring costs, other events). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Feb 29, 2024 | — |
| CORRESP | Letter to the SEC | Feb 27, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 16, 2024 | — |
| EFFECT | Filing | Mar 21, 2023 | — |
| CORRESP | Letter to the SEC | Mar 17, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2023 | — |
| D | Filing | Feb 21, 2023 | — |
| CT ORDER | Filing | Nov 16, 2021 | — |
| EFFECT | Filing | Mar 26, 2021 | — |
| CORRESP | Letter to the SEC | Mar 23, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2021 | — |
| EFFECT | Filing | May 13, 2020 | — |
| CORRESP | Letter to the SEC | May 8, 2020 | — |
| UPLOAD | Letter from the SEC | May 7, 2020 | — |
| EFFECT | Filing | Apr 14, 2020 | — |
| CORRESP | Letter to the SEC | Apr 10, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2020 | — |
| D | Filing | Jan 31, 2020 | — |
| D | Filing | Dec 12, 2019 | — |
| EFFECT | Filing | Oct 7, 2019 | — |
| CORRESP | Letter to the SEC | Oct 3, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 3, 2019 | — |
| CT ORDER | Filing | Dec 17, 2018 | — |
| CT ORDER | Filing | Oct 1, 2018 | — |
| D | Filing | Sep 21, 2018 | — |
| EFFECT | Filing | Dec 11, 2017 | — |
| EFFECT | Filing | Dec 8, 2017 | — |
| CORRESP | Letter to the SEC | Dec 8, 2017 | — |
| CORRESP | Letter to the SEC | Dec 8, 2017 | — |
| CORRESP | Letter to the SEC | Dec 7, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2017 | — |
| D | Filing | Aug 22, 2017 | — |
| EFFECT | Filing | Jul 27, 2017 | — |
| CT ORDER | Filing | May 12, 2017 | — |
| CORRESP | Letter to the SEC | May 11, 2017 | — |
| CORRESP | Letter to the SEC | Apr 4, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2017 | — |
| NT 10-Q | Filing | Nov 15, 2016 | Sep 30, 2016 |
| EFFECT | Filing | May 10, 2016 | — |
| CORRESP | Letter to the SEC | May 9, 2016 | — |
| CORRESP | Letter to the SEC | May 9, 2016 | — |
| CORRESP | Letter to the SEC | May 5, 2016 | — |
| CORRESP | Letter to the SEC | May 5, 2016 | — |
| CERTNAS | Auto-generated paper document | May 3, 2016 | — |
| 8-A12B | Form 8-a12b | May 3, 2016 | — |
| CORRESP | Letter to the SEC | Apr 14, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2016 | — |
| EFFECT | Filing | Aug 28, 2015 | — |
| CORRESP | Letter to the SEC | Aug 25, 2015 | — |
| D | Filing | Aug 6, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2015 | — |
| RW | Filing | Dec 5, 2014 | — |
| NT 10-Q | This is a nt 10-q attachment file in htm format. | Nov 14, 2014 | Sep 30, 2014 |
| EFFECT | Filing | Aug 7, 2014 | — |
| CORRESP | Letter to the SEC | Aug 7, 2014 | — |
| CORRESP | Letter to the SEC | Jul 28, 2014 | — |
| CORRESP | Letter to the SEC | Jul 28, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2014 | — |
| CORRESP | Letter to the SEC | Jul 25, 2014 | — |
| CORRESP | Letter to the SEC | Jul 25, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2014 | — |
| CORRESP | Letter to the SEC | Jul 16, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2014 | — |
| CORRESP | Letter to the SEC | Jul 3, 2014 | — |
| D | Filing | Jun 30, 2014 | — |
| UPLOAD | Letter from the SEC | May 22, 2014 | — |
| NT 10-K | This is a nt 10-k attachment file in htm format. | Jul 1, 2013 | Mar 31, 2013 |
| NT 10-K | This is a nt 10-k attachment file in htm format. | Jun 29, 2012 | Mar 31, 2012 |
| D | Filing | Mar 7, 2012 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2012 | — |
| CORRESP | Letter to the SEC | Jan 4, 2012 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2012 | — |
| CORRESP | Letter to the SEC | Dec 16, 2011 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2011 | — |
| CORRESP | Letter to the SEC | Nov 21, 2011 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2011 | — |
| CORRESP | Letter to the SEC | Oct 25, 2011 | — |
| CORRESP | Letter to the SEC | Oct 12, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2011 | — |
| CORRESP | Letter to the SEC | Sep 15, 2011 | — |
| PRER14A | Amended pre 14a | Sep 15, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2011 | — |
| NT 10-Q | Vistagen nt 10q june 30 2011 | Aug 16, 2011 | Jun 30, 2011 |
| SC 14F1/A | Schedule 14f-1 | Jun 8, 2011 | — |
| SC 14F1 | Schedule 14f-1 | May 26, 2011 | — |
| 8-A12G | Filing | Jun 18, 2010 | — |
| 10QSB | Filing | May 7, 2008 | Mar 31, 2008 |
| 10KSB | Filing | Mar 7, 2008 | Dec 31, 2007 |
| 10QSB | Filing | Nov 5, 2007 | Sep 30, 2007 |
| EFFECT | Filing | Sep 24, 2007 | — |
| SB-2 | Filing | Sep 11, 2007 | — |
Showing 92 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VTGN (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1411685
- Former names
- Excaliber Enterprises, Ltd. (until Jun 8, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.